About this Journal Submit a Manuscript Table of Contents
Clinical and Developmental Immunology
Volume 2013 (2013), Article ID 607073, 6 pages
http://dx.doi.org/10.1155/2013/607073
Review Article

T Helper 17 Cells in Autoimmune Liver Diseases

Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Shitsukawa, To-on, Ehime 791-0295, Japan

Received 3 May 2013; Revised 16 August 2013; Accepted 9 September 2013

Academic Editor: Aurelia Rughetti

Copyright © 2013 Masanori Abe et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. R. Mosmann, H. Cherwinski, and M. W. Bond, “Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins,” The Journal of Immunology, vol. 136, no. 7, pp. 2348–2357, 1986. View at Scopus
  2. L. E. Harrington, R. D. Hatton, P. R. Mangan et al., “Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages,” Nature Immunology, vol. 6, no. 11, pp. 1123–1132, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Park, Z. Li, X. O. Yang et al., “A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17,” Nature Immunology, vol. 6, no. 11, pp. 1133–1141, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Sakaguchi, “Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses,” Annual Review of Immunology, vol. 22, pp. 531–562, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Bettelli, M. Oukka, and V. K. Kuchroo, “TH-17 cells in the circle of immunity and autoimmunity,” Nature Immunology, vol. 8, no. 4, pp. 345–350, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. C. M. Costanino, C. M. Baecher-Allan, and D. A. Hafler, “Human regulatory T cells and autoimmunity,” European Journal of Immunology, vol. 38, no. 4, pp. 921–924, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. W. Ouyang, J. K. Kolls, and Y. Zheng, “The biological functions of T helper 17 cell effector cytokines in inflammation,” Immunity, vol. 28, no. 4, pp. 454–467, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Korn, E. Bettelli, M. Oukka, and V. K. Kuchroo, “IL-17 and Th17 cells,” Annual Review of Immunology, vol. 27, pp. 485–517, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. J. K. Kolls and A. Lindén, “Interleukin-17 family members and inflammation,” Immunity, vol. 21, no. 4, pp. 467–476, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Ye, F. H. Rodriguez, S. Kanaly et al., “Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense,” Journal of Experimental Medicine, vol. 194, no. 4, pp. 519–527, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Nurieva, X. O. Yang, G. Martinez et al., “Essential autocrine regulation by IL-21 in the generation of inflammatory T cells,” Nature, vol. 448, no. 7152, pp. 480–483, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Korn, E. Bettelli, W. Gao et al., “IL-21 initiates an alternative pathway to induce proinflammatory T H17 cells,” Nature, vol. 448, no. 7152, pp. 484–487, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. P. R. Mangan, L. E. Harrington, D. B. O'Quinn et al., “Transforming growth factor-β induces development of the TH17 lineage,” Nature, vol. 441, no. 7090, pp. 231–234, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Bettelli, Y. Carrier, W. Gao et al., “Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells,” Nature, vol. 441, no. 7090, pp. 235–238, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Zhou, I. I. Ivanov, R. Spolski et al., “IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways,” Nature Immunology, vol. 8, no. 9, pp. 967–974, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. M. J. McGeachy, Y. Chen, C. M. Tato et al., “The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo,” Nature Immunology, vol. 10, no. 3, pp. 314–324, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. I. I. Ivanov, B. S. McKenzie, L. Zhou et al., “The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells,” Cell, vol. 126, no. 6, pp. 1121–1133, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. X. O. Yang, A. D. Panopoulos, R. Nurieva et al., “STAT3 regulates cytokine-mediated generation of inflammatory helper T cells,” The Journal of Biological Chemistry, vol. 282, no. 13, pp. 9358–9363, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Yang, D. E. Anderson, C. Baecher-Allan et al., “IL-21 and TGF-β are required for differentiation of human TH17 cells,” Nature, vol. 454, no. 7202, pp. 350–352, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Manel, D. Unutmaz, and D. R. Littman, “The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt,” Nature Immunology, vol. 9, no. 6, pp. 641–649, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Volpe, N. Servant, R. Zollinger et al., “A critical function for transforming growth factor-β, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses,” Nature Immunology, vol. 9, no. 6, pp. 650–657, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Zhou, J. E. Lopes, M. M. W. Chong et al., “TGF-beta-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function,” Nature, vol. 453, no. 7192, pp. 236–240, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. W. Chen, W. Jin, N. Hardegen et al., “Conversion of peripheral CD4+CD25 naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3,” Journal of Experimental Medicine, vol. 198, no. 12, pp. 1875–1886, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. M. O. Li, S. Sanjabi, and R. Flavell, “Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms,” Immunity, vol. 25, no. 3, pp. 455–471, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Laurence, C. M. Tato, T. S. Davidson et al., “Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation,” Immunity, vol. 26, no. 3, pp. 371–381, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Mucida, Y. Park, G. Kim et al., “Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid,” Science, vol. 317, no. 5835, pp. 256–260, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. M. R. Walker, D. J. Kasprowicz, V. H. Gersuk et al., “Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25 T cells,” Journal of Clinical Investigation, vol. 112, no. 9, pp. 1437–1443, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Zheng and A. Y. Rudensky, “Foxp3 in control of the regulatory T cell lineage,” Nature Immunology, vol. 8, no. 5, pp. 457–462, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. K. S. Voo, Y. Wang, F. R. Santori et al., “Identification of IL-17-producing FOXP3+ regulatory T cells in humans,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 12, pp. 4793–4798, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. F. Zhang, G. Meng, and W. Strober, “Interactions among the transcription factors Runx1, RORγt and Foxp3 regulate the differentiation of interleukin 17-producing T cells,” Nature Immunology, vol. 9, no. 11, pp. 1297–1306, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Du, C. Huang, B. Zhou, and S. F. Ziegler, “Isoform-specific inhibition of RORα-mediated transcriptional activation by human FOXP3,” The Journal of Immunology, vol. 180, no. 7, pp. 4785–4792, 2008. View at Scopus
  32. L. Steinman, “A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage,” Nature Medicine, vol. 13, no. 2, pp. 139–145, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. D. J. Cua, J. Sherlock, Y. Chen et al., “Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain,” Nature, vol. 421, no. 6924, pp. 744–748, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. C. A. Murphy, C. L. Langrish, Y. Chen et al., “Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation,” Journal of Experimental Medicine, vol. 198, no. 12, pp. 1951–1957, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. D. Yen, J. Cheung, H. Scheerens et al., “IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6,” Journal of Clinical Investigation, vol. 116, no. 5, pp. 1310–1316, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. M. A. Lowes, T. Kikuchi, J. Fuentes-Duculan et al., “Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells,” Journal of Investigative Dermatology, vol. 128, no. 5, pp. 1207–1211, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. J. S. Tzartos, M. A. Friese, M. J. Craner et al., “Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis,” American Journal of Pathology, vol. 172, no. 1, pp. 146–155, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. F. Lafdil, A. M. Miller, S. H. Ki, and B. Gao, “Th17 cells and their associated cytokines in liver diseases,” Cellular and Molecular Immunology, vol. 7, no. 4, pp. 250–254, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. L. Zhao, D. K. Qiu, and X. Ma, “Th17 cells: the emerging reciprocal partner of regulatory T cells in the liver,” Journal of Digestive Diseases, vol. 11, no. 3, pp. 126–133, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. L. Hammerich, F. Heymann, and F. Tacke, “Role of IL-17 and Th17 cells in liver diseases,” Clinical and Developmental Immunology, vol. 2011, Article ID 345803, 12 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. C. Ye, W. Li, M. Zheng, and Y. Chen, “T-helper 17 cell: a distinctive cell in liver diseases,” Hepatology Research, vol. 41, no. 1, pp. 22–29, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. E. L. Krawitt, “Autoimmune hepatitis,” The New England Journal of Medicine, vol. 354, no. 1, pp. 54–66, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Abe, T. Mashiba, M. Zeniya, K. Yamamoto, M. Onji, and H. Tsubouchi, “Present status of autoimmune hepatitis in Japan: a nationwide survey,” Journal of Gastroenterology, vol. 46, no. 9, pp. 1136–1141, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. L. Zhao, Y. Tang, Z. You et al., “Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression,” PLoS ONE, vol. 6, no. 4, Article ID e18909, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. M. S. Longhi, Y. Ma, D. P. Bogdanos, P. Cheeseman, G. Mieli-Vergani, and D. Vergani, “Impairment of CD4+CD25+ regulatory T-cells in autoimmune liver disease,” Journal of Hepatology, vol. 41, no. 1, pp. 31–37, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. M. S. Longhi, M. J. Hussain, R. R. Mitry et al., “Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis,” The Journal of Immunology, vol. 176, no. 7, pp. 4484–4491, 2006. View at Scopus
  47. S. Ferri, M. S. Longhi, C. De Molo et al., “A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis,” Hepatology, vol. 52, no. 3, pp. 999–1007, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. M. S. Longhi, F. Meda, P. Wang et al., “Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis,” Hepatology, vol. 47, no. 2, pp. 581–591, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. M. S. Longhi, R. Liberal, B. Holder, et al., “Inhibition of interleukin-17 promotes differentiation of CD25 cells into stable T regulatory cells in patients with autoimmune hepatitis,” Gastroenterology, vol. 142, no. 7, pp. 1526–1535, 2012.
  50. M. M. Kaplan and M. E. Gershwin, “Primary biliary cirrhosis,” The New England Journal of Medicine, vol. 353, no. 12, pp. 1261–1273, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Abe and M. Onji, “Natural history of primary biliary cirrhosis,” Hepatology Research, vol. 38, no. 7, pp. 639–645, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. K. Wakabayashi, Z. X. Lian, Y. Moritoki et al., “IL-2 receptor α−/− mice and the development of primary biliary cirrhosis,” Hepatology, vol. 44, no. 5, pp. 1240–1249, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. R. Y. Lan, T. L. Salunga, K. Tsuneyama et al., “Hepatic IL-17 responses in human and murine primary biliary cirrhosis,” Journal of Autoimmunity, vol. 32, no. 1, pp. 43–51, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. G. Rong, Y. Zhou, Y. Xiong et al., “Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population,” Clinical and Experimental Immunology, vol. 156, no. 2, pp. 217–225, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. D. Fenoglio, F. Bernuzzi, F. Battaglia, et al., “Th17 and regulatory T lymphocytes in primary biliary cirrhosis and systemic sclerosis as models of autoimmune fibrotic diseases,” Autoimmunity Reviews, vol. 12, no. 2, pp. 300–304, 2012.
  56. K. Harada, S. Shimoda, Y. Sato, K. Isse, H. Ikeda, and Y. Nakanuma, “Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis,” Clinical and Experimental Immunology, vol. 157, no. 2, pp. 261–270, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. R. Y. Lan, C. Cheng, Z. X. Lian et al., “Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis,” Hepatology, vol. 43, no. 4, pp. 729–737, 2006. View at Publisher · View at Google Scholar · View at Scopus
  58. M. G. Silveira and K. D. Lindor, “Primary sclerosing cholangitis,” Canadian Journal of Gastroenterology, vol. 22, no. 8, pp. 3338–3349, 2008.
  59. K. W. Burak, P. Angulo, and K. D. Lindor, “Is there a role for liver biopsy in primary sclerosing cholangitis?” American Journal of Gastroenterology, vol. 98, no. 5, pp. 1155–1158, 2003. View at Publisher · View at Google Scholar · View at Scopus
  60. J. Katt, D. Schwinge, T. Schoknecht, et al., “Increased T heler type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis,” Hepatology, vol. 58, no. 3, pp. 1084–1093, 2013. View at Publisher · View at Google Scholar
  61. F. Meng, K. Wang, T. Aoyama, et al., “Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice,” Gastroenterology, vol. 143, no. 3, pp. 765–776, 2012.
  62. P. Fickert, U. Stöger, A. Fuchsbichler et al., “A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis,” American Journal of Pathology, vol. 171, no. 2, pp. 525–536, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. E. Björnsson, S. T. Chari, T. C. Smyrk, and K. Lindor, “Immunoglobulin G4 associated cholangitis: description of an emerging clinical entity based on review of the literature,” Hepatology, vol. 45, no. 6, pp. 1547–1554, 2007. View at Publisher · View at Google Scholar · View at Scopus
  64. Y. Zen, T. Fujii, K. Harada et al., “Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis,” Hepatology, vol. 45, no. 6, pp. 1538–1546, 2007. View at Publisher · View at Google Scholar · View at Scopus
  65. T. Müller, C. Beutler, A. H. Picó, et al., “Increased T-helper 2 cytokines in bile from patients with IgG4-related cholangitis disrupt the tight junction-associated biliary epithelial cell barrier,” Gastroenterology, vol. 144, no. 5, pp. 1116–1128, 2013.
  66. M. Koyabu, K. Uchida, H. Miyoshi et al., “Analysis of regulatory T cells and IgG4-positive plasma cells among patients of IgG4-related sclerosing cholangitis and autoimmune liver diseases,” Journal of Gastroenterology, vol. 45, no. 7, pp. 732–741, 2010. View at Publisher · View at Google Scholar · View at Scopus
  67. H. Q. Sun, J. Y. Zhang, H. Zhang, Z. S. Zou, F. S. Wang, and J. H. Jia, “Increased Th17 cells contribute to disease progression in patients with HBV-associated liver cirrhosis,” Journal of Viral Hepatitis, vol. 19, no. 6, pp. 396–403, 2012. View at Publisher · View at Google Scholar · View at Scopus
  68. Z. Tan, X. Qian, R. Jiang, et al., “IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation,” The Journal of Immunology, vol. 191, no. 4, pp. 1835–1844, 2013.
  69. M. Hara, H. Kono H, S. Furuya, et al., “Interleukin-17A plays a pivotal role in cholestatic liver fibrosis,” Journal of Surgical Research, vol. 183, no. 2, pp. 574–582, 2013.
  70. J. Ge, K. Wang, Q. H. Meng, Z. X. Qi, F. L. Meng, and Y. C. Fan, “Implication of Th17 and Th1 cells in patients with chronic active hepatitis B,” Journal of Clinical Immunology, vol. 30, no. 1, pp. 60–67, 2010. View at Publisher · View at Google Scholar · View at Scopus
  71. A. Lemmers, C. Moreno, T. Gustot et al., “The interleukin-17 pathway is involved in human alcoholic liver disease,” Hepatology, vol. 49, no. 2, pp. 646–657, 2009. View at Publisher · View at Google Scholar · View at Scopus